Search - tctmd.com

Displaying 301 - 320 of 334

Sort: Relevancy | Date

Presentation TCT 2014

Meta-analyses Show This and Should Be Believed!

Presenter: Tullio Palmerini

September 14, 2014

Presentation TCT 2014

Optimal Duration of DAPT After Intracoronary Stenting: Current Status

Presenter: Roxana Mehran

September 13, 2014

Presentation

Issues with DAPT: An Expert Case-Based Discussion

Presenter: Jonathan Halperin, Ajay Kirtane, Roxana Mehran

July 29, 2014

Presentation

DAPT in Stable CAD in Modern Practice: Prevalence, Correlates, and Impact on Prognosis

Presenter: Gilles Lemesle

July 02, 2014

Presentation

Meta-analysis of RCTs Comparing Short-term vs Long-term DAPT following DES

Presenter: G. El-Hayek

May 19, 2014

Presentation CIT 2014

First Report of DAPT and CoCr Everolimus-Eluting Stent in Chinese Population: Two-Year Results from the Prospective Multicenter SEEDS Study-An Investigator Sponsored Study (ISS)

Presenter: Yelin Zhao

March 22, 2014

Presentation

Lack of Association Between DAPT Use and Stent Thrombosis Between 1 and 12 Months Following Resolute ZES Implantation

Presenter: 115704|Sigmund Silber

February 17, 2014

Presentation

Is Gender a Risk Factor? Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI): Results from the Real-World PARIS Reg

Presenter: Roxana Mehran

December 01, 2013

Presentation TCT 2013

The DAPT Duration Dilemma: Recent Trials and Reasonable Guidelines for Clinical Practice

Presenter: Dean Kereiakes

October 31, 2013

Presentation TCT 2013

The Conundrum of Switching DAPT

Presenter: Dean Kereiakes

October 31, 2013

Presentation TCT 2013

OPTIMIZE and ARTIC-INTERRUPTION: Perspectives on DAPT Duration after PCI

Presenter: Peter Wenaweser

October 31, 2013

Presentation TCT 2013

Optimal DAPT Duration Is Not Established: For Now Most Patients Should Stay on DAPT for at Least One Year!

Presenter: Edoardo Camenzind

October 31, 2013

Presentation TCT 2013

The Ongoing Saga of Short DAPT Therapy After DES: Navigating Device Evolution, New Pharmacotherapy, and Changing Clinical Practice Standards

Presenter: Roxana Mehran

October 30, 2013

Presentation

Mini-Review of the Latest ACC/AHA and ESC Guidelines on DAPT and PCI

Presenter: Stephan Windecker

October 29, 2013

Presentation TCT 2013

Triple Therapy (DAPT Plus Chronic Oral Anticoagulation): Risks and Therapeutic Alternatives

Presenter: Eugenia Nikolsky

October 28, 2013

Presentation

Short- vs. Long-term Duration of DAPT in Patients Treated for In-Stent Restenosis

Presenter: Gianluca Campo

October 23, 2013

Presentation ESC 2013

Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry

Presenter: 32040|Roxana Mehran

September 01, 2013

Presentation SOLACI 2013

The Importance of DAPT for the Stent

Presenter: Expedito E. Ribeiro

July 24, 2013

Presentation SOLACI 2013

DAPT for ACS: Focus on Patient Secondary Prevention

Presenter: Roberto Botelho

July 24, 2013

Presentation TVT 2013

Is Triple Therapy a Triple Threat for Patients? DAPT and Chronic Anticoagulation

Presenter: Ted Feldman

June 15, 2013

Advertisement

Meta-analyses Show This and Should Be Believed!

Optimal Duration of DAPT After Intracoronary Stenting: Current Status

Issues with DAPT: An Expert Case-Based Discussion

DAPT in Stable CAD in Modern Practice: Prevalence, Correlates, and Impact on Prognosis

Meta-analysis of RCTs Comparing Short-term vs Long-term DAPT following DES

First Report of DAPT and CoCr Everolimus-Eluting Stent in Chinese Population: Two-Year Results from the Prospective Multicenter SEEDS Study-An Investigator Sponsored Study (ISS)

Lack of Association Between DAPT Use and Stent Thrombosis Between 1 and 12 Months Following Resolute ZES Implantation

Is Gender a Risk Factor? Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI): Results from the Real-World PARIS Reg

The DAPT Duration Dilemma: Recent Trials and Reasonable Guidelines for Clinical Practice

The Conundrum of Switching DAPT

OPTIMIZE and ARTIC-INTERRUPTION: Perspectives on DAPT Duration after PCI

Optimal DAPT Duration Is Not Established: For Now Most Patients Should Stay on DAPT for at Least One Year!

The Ongoing Saga of Short DAPT Therapy After DES: Navigating Device Evolution, New Pharmacotherapy, and Changing Clinical Practice Standards

Mini-Review of the Latest ACC/AHA and ESC Guidelines on DAPT and PCI

Triple Therapy (DAPT Plus Chronic Oral Anticoagulation): Risks and Therapeutic Alternatives

Short- vs. Long-term Duration of DAPT in Patients Treated for In-Stent Restenosis

Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry

The Importance of DAPT for the Stent

DAPT for ACS: Focus on Patient Secondary Prevention

Is Triple Therapy a Triple Threat for Patients? DAPT and Chronic Anticoagulation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content